Phase I Safety and Tolerability Trial of CD19 Directed CAR T Cells in Adult Patients with B-Cell Acute Lymphoblastic Leukemia (B-ALL) with Minimal Residual Disease (MRD) Positivity at First Complete Remission
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
CTRC Inpatient
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Marc Schwartz](https://som.ucdenver.edu/FIMS/Content/faculty/31731/CU-Doctors-31731.jpg)
Marc Schwartz
Study ID
Protocol Number: 22-0054
More information available at ClinicalTrials.gov: NCT05535855
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers